Paper · 36926834
Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines.
Chen WA and 5 others. ACS Nano, 2023. Cited by 64 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines. Papers, record 36926834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36926834
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polyethylene Glycols | Major topic |
| Hypothermia | Major topic |
| Mice | |
| Humans | |
| Animals | |
| Nanomedicine | |
| Histamine | |
| Mice, Inbred C57BL | |
| Mice, Inbred NOD | |
| Mice, SCID | |
| Immunoglobulin G | |
| Immunity, Innate | |
| Liposomes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,755,943 | The role of complement in inflammation and phagocytosis. | Immunol Today | 1991 | https://conductscience.org/library/papers/1755943 | PubMed |
| 2 | 14,660,743 | Mast cells are required for experimental oral allergen-induced diarrhea. | J Clin Invest | 2003 | https://conductscience.org/library/papers/14660743 | PubMed |
| 3 | 27,804,292 | Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population. | Anal Chem | 2016 | https://conductscience.org/library/papers/27804292 | PubMed |
| 4 | 24,849,101 | Anaphylaxis and hypotension after administration of peginesatide. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24849101 | PubMed |
| 5 | 1,428,729 | Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. | Invest New Drugs | 1992 | https://conductscience.org/library/papers/1428729 | PubMed |
| 6 | 20,553,005 | Time evolution of the nanoparticle protein corona. | ACS Nano | 2010 | https://conductscience.org/library/papers/20553005 | PubMed |
| 7 | 29,363,548 | Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models. | Cancer Res | 2018 | https://conductscience.org/library/papers/29363548 | PubMed |
| 8 | 22,332,808 | Role of the methoxy group in immune responses to mPEG-protein conjugates. | Bioconjug Chem | 2012 | https://conductscience.org/library/papers/22332808 | PubMed |
| 9 | 23,810,240 | Rapid desensitization induces internalization of antigen-specific IgE on mouse mast cells. | J Allergy Clin Immunol | 2013 | https://conductscience.org/library/papers/23810240 | PubMed |
| 10 | 34,533,570 | Assessment of Allergic and Anaphylactic Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System. | JAMA Netw Open | 2021 | https://conductscience.org/library/papers/34533570 | PubMed |
1 to 10 of 95
See all 95 referencesCited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,923,377 | Zwitterionic Coatings for Urinary Catheters: Current Progress, Design Principles and Translational Challenges. | ACS Omega | 2026 | https://conductscience.org/library/papers/42923377 | PubMed |
| 42,799,454 | Immunogenicity Management Strategies for PEGylated Drug Delivery Systems. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42799454 | PubMed |
| 42,514,893 | Anti-PEG Immunogenicity of mRNA-LNP Vaccines in Humans: Evidence for Population-Level Changes in the Anti-PEG Antibody Repertoire. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514893 | PubMed |
| 42,400,029 | Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42400029 | PubMed |
| 42,193,329 | Effect of Short-Anchored PEGylated Lipids on Lipid Nanoparticle Characterization Profiles, Stability, and Efficacy. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193329 | PubMed |
| 42,176,005 | Aptamer-conjugated nanoparticles: emerging nano-enabled platforms for rapid and sensitive detection of viral infections. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42176005 | PubMed |
| 42,125,269 | Aptamer-Functionalized Nanocarriers for Bone and Joint Diseases: Engineering Design Rules and Translational Roadmap. | Small Sci | 2026 | https://conductscience.org/library/papers/42125269 | PubMed |
| 42,001,148 | Pre-existing anti-polyethylene glycol antibodies in pregnant women and newborns. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42001148 | PubMed |
| 41,942,053 | Therapeutic peptides and proteins: Status and developments in drug delivery. | J Control Release | 2026 | https://conductscience.org/library/papers/41942053 | PubMed |
| 41,558,674 | AFM-Based Single-Molecule Force Spectroscopy of PEG-Anti-PEG Antibody Interactions. | ACS Appl Bio Mater | 2026 | https://conductscience.org/library/papers/41558674 | PubMed |
1 to 10 of 30
See all 30 cited byGenes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C5AR1 | 728 | PubTator's text mining | https://conductscience.org/library/genes/728 | NCBI Gene |
| CCR3 | 1,232 | PubTator's text mining | https://conductscience.org/library/genes/1232 | NCBI Gene |
| CD82 | 3,732 | PubTator's text mining | https://conductscience.org/library/genes/3732 | NCBI Gene |
| FCGR2A | 2,212 | PubTator's text mining | https://conductscience.org/library/genes/2212 | NCBI Gene |
| FCGR3A | 2,214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| HSR | 338,386 | PubTator's text mining | https://conductscience.org/library/genes/338386 | NCBI Gene |
| KIT | 3,815 | PubTator's text mining | https://conductscience.org/library/genes/3815 | NCBI Gene |
| PCLAF | 9,768 | PubTator's text mining | https://conductscience.org/library/genes/9768 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36926834
GET https://conductscience.org/api/papers/v1/36926834/references?page=2